BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 12366428)

  • 1. Coexistence of localized Langerhans cell histiocytosis and cutaneous Rosai-Dorfman disease.
    Wang KH; Cheng CJ; Hu CH; Lee WR
    Br J Dermatol; 2002 Oct; 147(4):770-4. PubMed ID: 12366428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Cutaneous Rosai-Dorfman Disease and Localized Cutaneous Langerhans Cell Histiocytosis Within a Single Subcutaneous Nodule.
    Litzner BR; Subtil A; Vidal CI
    Am J Dermatopathol; 2015 Dec; 37(12):936-9. PubMed ID: 26588339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of neuroimaging features of histiocytic neoplasms with central nervous system involvement: a retrospective study of 121 adult patients.
    Fan X; Liu T; Zhang Z; Sun J; Niu N; Mao C; Wang F; Li J; Zhou D; Cao X; Jin Z; Feng F
    Eur Radiol; 2023 Nov; 33(11):8031-8042. PubMed ID: 37191919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unusual co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: report of a case and review of the literature.
    Cohen-Barak E; Rozenman D; Schafer J; Krausz J; Dodiuk-Gad R; Gabriel H; Shani-Adir A
    Int J Dermatol; 2014 May; 53(5):558-63. PubMed ID: 23968608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monokine expression in Langerhans' cell histiocytosis and sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
    Foss HD; Herbst H; Araujo I; Hummel M; Berg E; Schmitt-Gräff A; Stein H
    J Pathol; 1996 May; 179(1):60-5. PubMed ID: 8691347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of Langerhans cell histiocytosis, Rosai-Dorfman disease and splenic lymphoma with fatal outcome after rapid development of histiocytic sarcoma of the liver.
    Llamas-Velasco M; Cannata J; Dominguez I; García-Noblejas A; Aragües M; Fraga J; Arranz R
    J Cutan Pathol; 2012 Dec; 39(12):1125-30. PubMed ID: 23043641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous Rosai-Dorfman disease: clinicopathological profiles, spectrum and evolution of 21 lesions in six patients.
    Wang KH; Chen WY; Liu HN; Huang CC; Lee WR; Hu CH
    Br J Dermatol; 2006 Feb; 154(2):277-86. PubMed ID: 16433797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: possible relationship of two histiocytic disorders in rare cases.
    O'Malley DP; Duong A; Barry TS; Chen S; Hibbard MK; Ferry JA; Hasserjian RP; Thompson MA; Richardson MS; Jaffe R; Sidhu JS; Banks PM
    Mod Pathol; 2010 Dec; 23(12):1616-23. PubMed ID: 20729813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous adult xanthogranuloma with a small portion of BRAF
    Ishikawa M; Endo Y; Uehara A; Suto M; Yasuda M; Motegi SI; Ishikawa O
    J Dermatol; 2019 Feb; 46(2):161-165. PubMed ID: 30536719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistent Rosai Dorfman disease and Langerhans cell histiocytosis in an Orbital mass: A Case Report.
    Rastogi A; Jaisingh K; Rajurkar K; Saran RK; Singh M; Baindur S; Singiri D; Gaonker T
    Eur J Ophthalmol; 2023 May; 33(3):NP60-NP65. PubMed ID: 35229680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin D and E co-expression in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) and Langerhans' cell histiocytosis: further evidences of a phenotypic overlap between these histiocytic disorders.
    Paulli M; Feller AC; Boveri E; Kindl S; Berti E; Rosso R; Merz H; Facchetti F; Gambini C; Bonetti F
    Virchows Arch; 1994; 424(6):601-6. PubMed ID: 8055153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cutaneous revelation of Rosai-Dorfman disease: 7 cases].
    Vuong V; Moulonguet I; Cordoliani F; Crickx B; Bezier M; Vignon-Pennamen MD; Flageul B; Bagot M; Petit A
    Ann Dermatol Venereol; 2013 Feb; 140(2):83-90. PubMed ID: 23395488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
    Papo M; Cohen-Aubart F; Trefond L; Bauvois A; Amoura Z; Emile JF; Haroche J
    Curr Oncol Rep; 2019 May; 21(7):62. PubMed ID: 31115724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of isolated cutaneous Rosai-Dorfman-Syndrome.
    Rizwan MM; Chhabra G; Mishra A; Kapadia S; Rai R; Gill H
    Gulf J Oncolog; 2013 Jul; 1(14):87-9. PubMed ID: 23996873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological Manifestations of Histiocytic Disorders.
    Banks SA; Sartori Valinotti JC; Go RS; Abeykoon JP; Goyal G; Young JR; Koster MJ; Vassallo R; Ryu JH; Davidge-Pitts CJ; Ravindran A; Bennani NN; Shah MV; Rech KL; Tobin WO;
    Curr Neurol Neurosci Rep; 2023 Jun; 23(6):277-286. PubMed ID: 37209319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease.
    Simko SJ; Tran HD; Jones J; Bilgi M; Beaupin LK; Coulter D; Garrington T; McCavit TL; Moore C; Rivera-Ortegón F; Shaffer L; Stork L; Turcotte L; Welsh EC; Hicks MJ; McClain KL; Allen CE
    Pediatr Blood Cancer; 2014 Mar; 61(3):479-87. PubMed ID: 24106153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-existent Langerhans cell histiocytosis and Rosai-Dorfman disease: a diagnostic rarity.
    Sachdev R; Shyama J
    Cytopathology; 2008 Feb; 19(1):55-8. PubMed ID: 17388938
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous Rosai-Dorfman disease with increased number of eosinophils: coincidence or histologic variant?
    Cangelosi JJ; Prieto VG; Ivan D
    Arch Pathol Lab Med; 2011 Dec; 135(12):1597-600. PubMed ID: 22129191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia.
    Bonometti A; Ferrario G; Parafioriti A; Giardino D; Simonetti F; Ginori A; Passoni E; Berti E;
    J Cutan Pathol; 2021 May; 48(5):637-643. PubMed ID: 33188581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OCT2 expression in histiocytoses.
    Ungureanu IA; Cohen-Aubart F; Héritier S; Fraitag S; Charlotte F; Lequain H; Hélias-Rodzewicz Z; Haroche J; Donadieu J; Emile JF
    Virchows Arch; 2023 Jul; 483(1):81-86. PubMed ID: 36754897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.